AI assistant
Protagonist Therapeutics, Inc — Director's Dealing 2019
Nov 27, 2019
31163_dirs_2019-11-27_f386cf8c-2ee8-4707-bba0-a57293905ec8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2019-11-26
Reporting Person: PATEL DINESH V PH D (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-26 | Common Stock | M | 4000 | $1.16 | Acquired | 379824 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-11-26 | Stock Option (right to buy) | $1.16 | M | 4000 | Disposed | 2025-10-28 | Common Stock (4000) | Direct |
Footnotes
F1: Includes 1,032 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2019.
F2: 1/4th of the shares subject to the option shall vest on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option shall vest on the last day of each month following the first anniversary of the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.